Dietary supplementationa | Statistical significance of variance ratio (P)b, effects of | ||||||
---|---|---|---|---|---|---|---|
Control | TTA | FO | TTA + FO | TTA | FO | TTA*FO | |
CPT-I | 2.79 ± 0.26c | 1.69 ± 0.38 | 2.54 ± 0.12 | 1.75 ± 0.14 | <0.001 | 0.22 | 0.06 |
CPT-I (with malonyl-CoA) | 1.89 ± 0.21 | 1.23 ± 0.28 | 1.77 ± 0.14 | 1.31 ± 0.13 | <0.001 | 0.73 | 0.14 |
CPT-II | 10.79 ± 1.03 | 23.55 ± 3.15 | 12.40 ± 2.33 | 22.39 ± 4.32 | <0.001 | 0.82 | 0.15 |
ACOX | 1.65 ± 0.31 | 4.53 ± 1.16 | 4.61 ± 1.41 | 8.47 ± 1.37 | <0.001 | <0.001 | 0.19 |
GPAT | 0.25 ± 0.06 | 0.43 ± 0.09 | 0.39 ± 0.09 | 0.64 ± 0.14 | <0.001 | <0.001 | 0.37 |
FAS | 0.04 ± 0.01 | 0.09 ± 0.01 | 0.06 ± 0.02 | 0.10 ± 0.02 | <0.001 | 0.01 | 0.34 |